These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4442447)

  • 1. Pharmacologic activity of stereoisomers of 1-substituted 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines: inhibition of 3H-dopamine accumulation by rat brain slices and lipolytic activity with isolated mouse fat cells.
    Cohen G; Heikkila RE; Dembiec D; Sang D; Teitel S; Brossi A
    Eur J Pharmacol; 1974 Dec; 29(2):292-7. PubMed ID: 4442447
    [No Abstract]   [Full Text] [Related]  

  • 2. Phosphodiesterase inhibition and lipolytic action of the stereoisomers of trimetoquinol.
    Piascik MT; Miller DD; Feller DR
    Res Commun Chem Pathol Pharmacol; 1976 Feb; 13(2):203-15. PubMed ID: 176706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the optical isomers of tetrahydroisoquinolines in rat adipose tissue and guinea pig aorta.
    Lee OS; Mears JA; Miller DD; Feller DR
    Eur J Pharmacol; 1974 Sep; 28(1):225-9. PubMed ID: 4430326
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of substituted tetrahydroisoquinolines and catecholamines on lipolysis, in vitro. II. Stereoselectivity.
    Shonk RF; Miller DD; Feller DR
    Biochem Pharmacol; 1971 Dec; 20(12):3403-12. PubMed ID: 5132887
    [No Abstract]   [Full Text] [Related]  

  • 5. The inhibition of (3H) biogenic amine accumulation into rat brain tissue slices by various tryptamine derivatives.
    Heikkila RE; Cohen G
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):539-47. PubMed ID: 4824828
    [No Abstract]   [Full Text] [Related]  

  • 6. Antidopaminergic effects of 1,2,3,4-tetrahydroisoquinoline and salsolinol.
    Antkiewicz-Michaluk L; Michaluk J; Romańska I; Papla I; Vetulani J
    J Neural Transm (Vienna); 2000; 107(8-9):1009-19. PubMed ID: 11041279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex.
    Heikkila RE; Orlansky H; Mytilineou C; Cohen G
    J Pharmacol Exp Ther; 1975 Jul; 194(1):47-56. PubMed ID: 1151755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical investigations in vitro with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in preparations of rat brain.
    Markstein R; Lahaye D
    Eur J Pharmacol; 1984 Nov; 106(2):301-11. PubMed ID: 6335691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A metabolic approach to the detection of tetrahydroisoquinoline formation from 3H-dopamine in rat brain following treatment with ethanol or chloral hydrate.
    Shier WT; Koda LY; Bloom FE
    Prog Clin Biol Res; 1982; 90():191-200. PubMed ID: 7111319
    [No Abstract]   [Full Text] [Related]  

  • 10. Stereoselective interaction of tetrahydroisoquinolines in beta-adrenoceptor systems.
    Piascik MT; Osei-Gyimah P; Miller DD; Feller DR
    Eur J Pharmacol; 1978 Apr; 48(4):393-401. PubMed ID: 25778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lipolytic action of growth hormone and glucocorticoid by ultraviolet and x-radiation.
    Fain JN
    Science; 1967 Sep; 157(3792):1062-4. PubMed ID: 6036236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Adrenoceptor blocking activity of 1-substituted trimetoquinol analogs.
    Piascik MT; Osei-Gyimah P; Miller DD; Feller DR
    Biochem Pharmacol; 1979 Jun; 28(11):1807-10. PubMed ID: 38798
    [No Abstract]   [Full Text] [Related]  

  • 13. Opposite effect of simple tetrahydroisoquinolines on amphetamine- and morphine-stimulated locomotor activity in mice.
    Vetulani J; Nalepa I; Antkiewicz-Michaluk L; Sansone M
    J Neural Transm (Vienna); 2001; 108(5):513-26. PubMed ID: 11459073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine-derived tetrahydroisoquinoline alkaloids--inhibitors of neuroamine metabolism.
    Collins AC; Cashaw JL; Davis VE
    Biochem Pharmacol; 1973 Sep; 22(18):2337-48. PubMed ID: 4733684
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-receptor-related stereoselectivities in fat cells.
    DeSantis LM; Feller DR; Patil PN
    Eur J Pharmacol; 1974 Oct; 28(2):302-9. PubMed ID: 4370612
    [No Abstract]   [Full Text] [Related]  

  • 16. Preparation and sensitivity of isolated fat cells of the rat to a serum lipolytic agonist.
    Curtis-Prior PB
    Guys Hosp Rep; 1972; 121(2):167-72. PubMed ID: 4666102
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of amantadine as a releasing agent or uptake blocker for H 3 -dopamine in rat brain slices.
    Heikkila RE; Cohen G
    Eur J Pharmacol; 1972 Nov; 20(2):156-60. PubMed ID: 4651205
    [No Abstract]   [Full Text] [Related]  

  • 18. 1-methyl-1,2,3,4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain.
    Antkiewicz-Michaluk L; Karolewicz B; Romańska I; Michaluk J; Bojarski AJ; Vetulani J
    Eur J Pharmacol; 2003 Apr; 466(3):263-9. PubMed ID: 12694809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipolytic activity of synthetic glucagon in isolated fat cells of rats.
    Hollmann M; Kettl H; Weinges KF
    Horm Metab Res; 1969 Nov; 1(6):317-8. PubMed ID: 5407094
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of benzydamine on the lipolytic system of fat cells.
    Dinnendahl V; Peters HD; Schönhöfer PS
    Biochem Pharmacol; 1976 Feb; 25(3):299-303. PubMed ID: 178318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.